PACB Sep 2024 7.000 put
| Previous Close | 5.50 |
| Open | 5.50 |
| Bid | 4.60 |
| Ask | 5.30 |
| Strike | 7.00 |
| Expire Date | 2024-09-20 |
| Day's Range | 5.50 - 5.50 |
| Contract Range | N/A |
| Volume | |
| Open Interest | N/A |
ZacksPacific Biosciences of California (PACB) Ascends While Market Falls: Some Facts to Note
Pacific Biosciences of California (PACB) concluded the recent trading session at $1.88, signifying a +1.62% move from its prior day's close.
ZacksPacBio's (PACB) Revio System to Boost Novogene's German Lab
PacBio (PACB) announces that Novogene is set to use PACB's Revio long-read sequencing system to expand the capabilities of its new lab in Munich, Germany.
GlobeNewswireNovogene to Power Cancer, Rare Disease, and Environmental Research with PacBio Sequencing
Highly accurate long-read sequencing data will be used at Novogene’s new lab in Munich, supporting customers across a network of leading research institutionsMENLO PARK, Calif., July 23, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced that Novogene is using its Revio long-read sequencing system to expand the capabilities of its new lab in Munich, Germany, serving customers across the European scientific co
